2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation

Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 3, 2000, Pages 294-301

  Jungehülsing, Markus ^a   Scheidhauer, Klemens ^a   Damm, Michael ^a   Pietrzyk, Uwe ^b   Eckel, Hans ^a   Schicha, Harald ^a   Stennert, Eberhard ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC ACCURACY; ENDOSCOPIC SURGERY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CANCER; NASOPHARYNX CARCINOMA; OUTPATIENT; PAROTID GLAND CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; ADENOCARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; NEOPLASM; SCINTISCANNING;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033624551     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2000.104807     Document Type: Article

References (36)

1. Unknown primary carcinoma: Natural history and prognostic factors in 657 consecutive patients
2. Cancer of unknown primary site
3. Diagnosis and therapy of occult primary tumor with lymph node metastases in the area of the head and neck
4. Metastases in carcinoma. Analysis of 1000 autopsied cases
5. Pathological evaluation of neoplasms with unknown primary tumor site
6. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin
7. Halsymphknotenmetastasen bei unbekanntem Primartumor. Verlaufsbeobachtung an 58 Patienten
8. Metabolic imaging by positron emission tomography in oncology
9. PET FDG studies in oncology
10. Neck dissection: Concepts, controversies, and technique
11. Cervical lymph nodes from an unknown primary tumor in 190 patients
12. Efficient stereospecific synthesis of non-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
13. Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI
14. A rational classification of neck dissections
15. FDG PET in head and neck cancer
16. Positron emission tomography: A new, precise imaging modality for the detection of primary head and neck tumors and assessment of cervical adenopathy
17. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation
18. Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI
19. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer?
20. Positron emission tomography (PET) in the evaluation of tumor proliferation and follow-up of therapy in ear, nose and throat tumors
21. Basic principles of positron emission tomography in oncology: Quantitation and whole body techniques
22. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose
23. Detection of unknown primary head and neck tumors by positron emission tomography
24. Detection of unknown occult primary tumors using positron emission tomography
25. Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor
26. An effective strategy for the evaluation of unknown primary tumors
27. Unknown primary squamous cell carcinoma metastatic to the neck
28. The biology of unknown primary tumors
29. Clinical implications of metastatic process
30. Unknown primary tumors: An example of accelerated (type 2) tumor progression
31. Gibt es die malignisierte laterale Halszyste doch?
32. Cancer in the neck without obvious source
33. Metastatic carcinoma in cervical lymph nodes from occult primary sites. A review
34. Detection of unknown occult primary tumors using positron emission tomography
35. Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET
36. Detection of scalene lymph node metastases from lung cancer. Positron emission tomography